Related Experiment Video
Updated: Mar 31, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9
Abstract:
Toxoplasma gondii, an important protozoan parasite, infects almost all warm-blooded animals and humans. Although treatments in T. gondii are limited by the lack of effective drugs, some calcium-dependent kinases were demonstrated as the promising drug targets to chemotherapy against T. gondii due to their essential roles in T. gondii and absence from their hosts. The objectives of the present study were to investigate the functions of six calcium-dependent protein kinases (CDPK4, CDPK4A, CDPK5, CDPK6, CDPK8, and CDPK9) in T. gondii to assess whether they are suitable for designing as drug targets. We used the CRISPR-Cas9 system to disrupt six CDPK genes successfully by insertion of DHFR* at the guide RNA-targeted region in the six endogenous CDPK loci and successfully obtained the six knockout (KO)-CDPK strains. The biological characteristics of the six strains were evaluated by plaque assays, invasion, egress, replication, and virulence assays, respectively. The results indicated that there was no significant difference between the six KO-CDPK strains and wild-type strain in virulence and the lytic cycle including invasion, egress, and replication. The conclusion was the six CDPKs are not essential for T. gondii lytic cycle and also not virulence factors for mice, suggesting that the six CDPKs may participate in other functions in T. gondii.
Insights
Six calcium-dependent protein kinases (CDPKs) in Toxoplasma gondii were investigated as potential drug targets. Gene knockout studies revealed these CDPKs are not essential for parasite survival or virulence.
Area of Science:
- Parasitology
- Molecular Biology
- Drug Discovery
Background:
- Toxoplasma gondii is a widespread protozoan parasite with limited treatment options.
- Calcium-dependent protein kinases (CDPKs) are potential drug targets due to their essential roles in T. gondii and absence in hosts.
Purpose of the Study:
- To investigate the functions of six specific CDPKs (CDPK4, CDPK4A, CDPK5, CDPK6, CDPK8, and CDPK9) in T. gondii.
- To assess their suitability as drug targets for T. gondii chemotherapy.
Main Methods:
- Utilized the CRISPR-Cas9 system to create knockout strains for six CDPK genes.
- Evaluated biological characteristics including plaque formation, invasion, egress, replication, and mouse virulence.
Main Results:
- Successfully generated six distinct knockout CDPK strains.
- No significant differences were observed in virulence or lytic cycle progression (invasion, egress, replication) compared to wild-type T. gondii.
Conclusions:
- The investigated six CDPKs are not essential for the T. gondii lytic cycle.
- These CDPKs do not appear to function as virulence factors in mouse models.
- Further research is needed to elucidate the roles of these CDPKs in other T. gondii functions.

